We collaborate with key stakeholders to develop and disseminate NIST products that enable comparison, ensure interoperability, and support commerce for emerging biotechnologies and engineering biology. We also lead and contribute to various Standards Developing Organizations (SDOs), including various ISO and ASTM technical committees.
Examples of standards leadership and development activities include:
ISO/TC 276: Biotechnology: NIST chairs and administers the U.S. Mirror Committee to ISO/TC 276: Biotechnology, which develops standards for all sectors of biotechnology. NIST has created an inclusive, collaborative environment among 40+ organizations to best represent U.S. interests while promoting international cooperation.
Advanced Therapies - Under the previsions enacted under the 21st Century Cures Act (Public Law 114–255), NIST continues to work with the U.S. FDA, the Standards Coordinating Body, and other stakeholders to coordinate the development of standards for regenerative medicine therapies.
Yeast RM: A living microbial RM consisting of freeze-dried Saccharomyces cerevisiae NE095 yeast cells is characterized for total cell count to compare and challenge cell enumeration and DNA-based detection technologies.